← All organizations
First clinical trial
Jan 1, 1999Last known activity
Jan 31, 2021
Acquired by Novartis on Oct 18, 2016
Timeline
1990s
- Jun 1, 1996
Endocyte— Founded
2010s
- Oct 18, 2016
Novartis— Acquired By
Drugs by trial phase (25 distinct, 33 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Crohn Disease
- Endometrial Neoplasms
- Head and Neck Neoplasms
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Multiple Sclerosis
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pituitary Diseases
- Pituitary Neoplasms
- Prostatic Neoplasms
- Testicular Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
Recent trials (44)
- NCT04663997CollaboratorPhase 2Jan 31, 2021
- NCT04430192CollaboratorPhase 1/Phase 2Jun 9, 2020
- NCT04419402CollaboratorPhase 2Jun 1, 2020
- NCT03494114CollaboratorPhase 1Aug 20, 2018
- NCT03511664Lead sponsorPhase 3May 23, 2018
- NCT03511664Study directorPhase 3May 23, 2018
- NCT03392428CollaboratorPhase 2Jan 29, 2018
- NCT03011320Lead sponsorPhase 1Jan 24, 2017
- NCT03011320Study directorPhase 1Jan 24, 2017
- NCT02202447Lead sponsorPhase 1May 1, 2014
- NCT02202447Study directorPhase 1May 1, 2014
- NCT01953536Lead sponsorPhase 2Apr 1, 2014
- NCT02049281Lead sponsorPhase 1Feb 1, 2014
- NCT01999738Lead sponsorPhase 1Oct 1, 2013
- NCT01999738Study directorPhase 1Oct 1, 2013
Details
- Founded
- West Lafayette, IN, US Jun 1, 1996
- Last known activity
- Jan 31, 2021